For all of these methods it is essential to measure the trade-off between attributes in multi-criteria decision situations for each participant or the group, and as such, adequate and understandable methods are essential. In order to find appropriate methods for measuring the benefits and for prioritizing them, beside the established methods, new approaches of decision making tools are transferred from other fields of research, like the marketing sector. Thus, one mean of evaluating these preferences and bringing them into accord is to take the required perspective for the situation. However, several studies have found a divergence in patients’ and physicians’ preferences or priorities regarding prevention and therapy (e.g. Therefore, while it is now important to measure the benefits and to prioritize the needs of patients, it will be even more so in the future. But also, other countries are interested in reliable methods to measure benefits for patients, for example, to support Health Technology Assessments by patient preferences.
![free download expert choice ahp free download expert choice ahp](https://flylib.com/books/4/222/1/html/2/images/08dts10.jpg)
In this context, patient-relevant outcomes have drawn greater attention because the added benefit for patients determines the reimbursement price. the Act on the Reform of the Market for Medicinal Products in 2011 (in German: AMNOG ). German politicians have adopted new laws to manage the costs of pharmaceuticals, e.g. Furthermore, innovations in medical care, such as equipment, pharmaceuticals, and treatment methods, are also driving up costs. Exacerbating this issue is the problem that many developed countries face, that is, the rising proportion of older, multimorbid patients, who serve to raise the cost of health care. The resources in health care systems are limited.